Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level Box-Behnken design

AAPS PharmSciTech
Ajay B SolankiRajesh H Parikh

Abstract

The aim of this study was to investigate the combined influence of 3 independent variables in the preparation of piroxicam proniosomes by the slurry method. A 3-factor, 3-level Box-Behnken design was used to derive a second-order polynomial equation and construct contour plots to predict responses. The independent variables selected were molar ratio of Span 60:cholesterol (X(1)), surfactant loading (X(2)), and amount of drug (X(3)). Fifteen batches were prepared by the slurry method and evaluated for percentage drug entrapment (PDE) and vesicle size. The transformed values of the independent variables and the PDE (dependent variable) were subjected to multiple regression to establish a full-model second-order polynomial equation. F was calculated to confirm the omission of insignificant terms from the full-model equation to derive a reduced-model polynomial equation to predict the PDE of proniosome-derived niosomes. Contour plots were constructed to show the effects of X(1), X(2) and X(3) on the PDE. A model was validated for accurate prediction of the PDE by performing checkpoint analysis. The computer optimization process and contour plots predicted the levels of independent variables X(1), X(2), and X(3) (0, -0.158 and -0.15...Continue Reading

References

Oct 15, 1978·Analytical Biochemistry·D W FryI D Goldman
Jan 1, 1992·Progress in Lipid Research·T Sato, J Sunamoto
Dec 15, 1989·Pharmaceutisch Weekblad. Scientific Edition·A Bast, R J Goris
Dec 1, 1985·The Journal of Pharmacy and Pharmacology·A J BaillieA Rogerson
Sep 8, 1970·Biochimica Et Biophysica Acta·R A Klein
Aug 1, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·M C Gohel, A F Amin
Jul 30, 1999·International Journal of Pharmaceutics·C Hu, D G Rhodes
Nov 27, 1999·Journal of Microencapsulation·A Namdeo, N K Jain
Mar 4, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·D LetourneurM Cansell
Jul 24, 2001·Pharmaceutical Research·A I Blazek-Welsh, D G Rhodes
Dec 14, 2001·AAPS PharmSci·A I Blazek-Welsh, D G Rhodes
Jan 28, 2003·Vaccine·Melissa J CoplandNigel M Davies
Mar 20, 2003·Journal of Pharmaceutical and Biomedical Analysis·M Gabriëls, J Plaizier-Vercammen
Nov 17, 2004·Free Radical Biology & Medicine·Alejandra N CimatoAlfredo A Hager
Nov 30, 2004·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·J Allen ZhangImran Ahmad
Apr 28, 2005·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Barbara RuoziMaria Angela Vandelli
Apr 28, 2006·The Journal of Pharmacy and Pharmacology·Minakshi GargNarendra Kumar Jain

❮ Previous
Next ❯

Citations

Apr 1, 2011·International Journal of Pharmaceutical Investigation·Bhupinder SinghRishi Kapil
Dec 5, 2013·Indian Journal of Pharmaceutical Sciences·Smita Rane, Bala Prabhakar
Jan 2, 2014·International Journal of Biological Macromolecules·M ShanmugaprakashA Manickam
Jun 20, 2014·International Journal of Biological Macromolecules·Savita SonawaneShamkant Shimpi
May 2, 2014·Journal of Liposome Research·Ming Ming WenAbeer A Kassem
Oct 17, 2013·Drug Delivery·Venkata Ramesh YasamGowthamarajan Kuppusamy
Oct 23, 2009·Journal of Drug Targeting·Adnan AzeemSushama Talegaonkar
Mar 31, 2012·Drug Development and Industrial Pharmacy·Ashok VelpulaPrabhakar Reddy Veerareddy
Jul 17, 2015·Artificial Cells, Nanomedicine, and Biotechnology·Ankur BhardwajAbhinav Mehta
Jan 23, 2016·Pharmaceutical Development and Technology·Mohammad Zaki AhmadMahmoud Mokhtar Ibrahim
Nov 2, 2011·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Karthik Y JangaPrabhakar Reddy Veerareddy
Dec 15, 2015·International Journal of Biological Macromolecules·Ravi R PatelBrahmeshwar Mishra
Jul 7, 2009·Journal of Hazardous Materials·Kaan YetilmezsoyRobert J Vanderbei
Oct 13, 2015·International Journal of Biological Macromolecules·Nilufer YukselA Tanju Ozcelikay
Mar 16, 2016·AAPS PharmSciTech·Ndidi C NgwulukaPadma V Devarajan
May 27, 2014·Pharmaceutical Development and Technology·Khalid M El-SayMajed Alsawahli
Jan 22, 2015·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Balaram GajraRavi Patel
Jan 10, 2017·Journal of Liposome Research·Neelu SinghShubhini A Saraf
Feb 9, 2018·Drug Development and Industrial Pharmacy·Mahmoud S SolimanHossam S El-Sawy
Dec 27, 2018·Current Pharmaceutical Design·Ankit JainJessica M Rosenholm
Jun 4, 2016·Drug Delivery and Translational Research·Jyotsana R MadanKamal Dua
Oct 21, 2015·Drug Delivery and Translational Research·Mangesh BhalekarAshwini Madgulkar
May 24, 2018·Environmental Science and Pollution Research International·Manel WakkelFéthi Zagrouba
Jun 24, 2020·Colloids and Surfaces. B, Biointerfaces·Josimar O EloyMarlus Chorilli
Nov 20, 2016·Food Chemistry·Maryam RavaghiAnna Maria Fadda

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.